Biography

Professor David Brayden is a Full Professor of Advanced Drug Delivery at University College Dublin, specialising in non-injectable drug delivery principles and technologies. Current work is funded by Science Foundation Ireland, the Department of Agriculture, Fisheries and Marine, the European Commission, and by biotech companies. Current projects carried out by his team of PhD candidates and post-doctoral Fellows include investigation of nanoparticles as carriers for oral insulin for diabetes, methods to enable oral delivery of food-derived molecules to lower blood pressure, a nanoparticle for resolving inflammation in arthritic joints, and buccal delivery of a GLP-1 analogue. He is a Fellow of the CRS and AAPS and a member of the EU Academy of Sciences. David is the Chief Editor of Frontiers in Drug Delivery since 2021. He serves as a member of Ireland's National Research Ethics Committee for Clinical Trials since 2021.